Time-dependent plasma protein changes in streptozotocin-induced diabetic rats before and after fungal polysaccharide treatments.
Previous studies about protein modulation with chemically induced models of diabetes in animals have yielded conflicting results, in that many investigators have reported different regulation patterns for the same proteins. Therefore, it is reasonable to determine biomarkers for prognosis and diagnosis of diabetes with time profiling for the candidate proteins. In this regard, we examined the influence of hypoglycemic fungal polysaccharides (EPS) on the time-dependent plasma protein alterations in streptozotocin-induced diabetic rats. The 2-DE analysis of rat plasma demonstrated that about 50 proteins from about 900 visualized spots were found to be differentially regulated, of which 20 spots were identified as principal diabetes-associated proteins. The results of time profiling revealed that most of the identified proteins showed significant alterations in a time-dependent manner during 14 days, with notable trends. Nine out of the twenty proteins displayed very similar time profiles between normal healthy and EPS-treated diabetic rats. Interestingly, the altered profiles of several proteins by diabetes induction almost returned to control levels after EPS treatments. In particular, we found a clear distinction in differential expression of oxidative stress proteins (ceruloplasmin and transferrin) and lipid metabolism related proteins (Apo A-I, Apo A-IV, and Apo E) in the STZ-induced diabetic rats. The data presented here have identified and characterized the time-dependent changes in plasma proteins associated with EPS treatment in STZ-induced diabetic rats, thereby leading to the discovery of early-response and late-response biomarkers in diabetic and EPS-treated states.
Kim
Sang Woo
SW
Department of Biotechnology, and Department of Bioindustry, Daegu University, Kyungsan, Kyungbuk 712-714, Korea.
Hwang
Hye Jin
HJ
Cho
Eun Jae
EJ
Oh
Jung Young
JY
Baek
Yu-Mi
YM
Choi
Jang Won
JW
Yun
Jong Won
JW
D000818:Animals; D001053:Apolipoproteins / Q000097:blood; D001487:Basidiomycota; D001798:Blood Proteins / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification / Q000378:metabolism*; D003921:Diabetes Mellitus, Experimental / Q000097:blood*; D015180:Electrophoresis, Gel, Two-Dimensional; D005786:Gene Expression Regulation / Q000187:drug effects; D005951:Glucose Tolerance Test; D007091:Image Processing, Computer-Assisted; D007700:Kinetics; D008297:Male; D018384:Oxidative Stress; D011134:Polysaccharides / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley
D001053:Apolipoproteins; D001798:Blood Proteins; D011134:Polysaccharides